Pitango Venture Capital Management Israel Ltd

10/15/2025 | Press release | Archived content

What Do Quantum Investors Look For

What Do Quantum Investors Look For?

Pitango | October 15, 2025

Short answer: investors in quantum computing look for exceptional scientific and technical depth, evidence that the approach works, a defensible advantage, and a credible path from research to real-world application. Development timelines can be significantly longer than in software, so investors need to understand both the science and the path required to turn it into a scalable company. Pitango First invests in seed and early-stage companies across quantum computing, AI, infrastructure, and cybersecurity.

Quantum presents a distinct fundraising challenge for founders. The technology is genuinely hard, the commercial market is still forming, and evaluating progress often requires technical expertise beyond traditional venture diligence. Investors with experience in the field tend to focus on a specific set of technical and commercial questions.

What do investors look for in a quantum company?

At the earliest stages, the team carries significant weight. Quantum hardware and algorithms demand deep, highly specialized expertise, and the number of people working at the frontier of the field remains relatively small. Relevant signals may include published research, experience building systems in leading laboratories, or work on advanced quantum programs in academia, national research institutes, or technology companies.

Beyond credentials, they look for whether the team can pull others in. Scientific excellence matters, but so does the ability to build a team around it. A founder who can attract other exceptional researchers and engineers has an important advantage in a field where specialized talent is scarce.

The rest of the evaluation clusters around a few points:

  • A defensible technical approach, with an honest account of where it beats the alternatives and where it doesn't.
  • Evidence that the core technical approach works beyond theory, at the level of maturity the company has reached.
  • A specific first application, not a list of every industry quantum might touch someday.
  • A realistic capital plan, particularly for hardware-intensive approaches where development can require significant investment over time.

Is proof of concept required before raising?

You don't necessarily need a commercial product, but you do need credible evidence that the core technical approach works. Investors will distinguish between a theoretical claim and a result that has been demonstrated or measured, with the latter providing a much stronger basis for evaluation.

What counts as proof varies by what you're building. A hardware company might show qubit coherence times, gate fidelity, or error rates measured on real devices. An algorithms or software company might show a demonstrated reduction in logical error rates. The relevant proof depends heavily on where the company sits in the quantum stack.

Peer-reviewed research can carry meaningful weight in quantum because it provides a degree of external scientific scrutiny that is less common in many other technology sectors. Results that have not been externally validated may require additional technical diligence, sometimes with independent scientific experts involved in the process.

How much do patents and intellectual property matter?

Intellectual property can play a significant role in quantum, particularly where the company's advantage is rooted in physics, engineering, or proprietary technical processes. Where the advantage lives in physics and engineering rather than in speed of execution, patents are a meaningful part of the defensive position, especially for hardware, control systems, fabrication methods, and error correction.

Investors examine the portfolio for real coverage rather than volume: filings that protect the core method, freedom to operate in the markets you're targeting, and clean ownership.

Ownership is particularly important. Plenty of quantum companies spin out of universities or national labs, and the licensing terms that come with a spinout can affect what the company owns, controls, and is able to commercialize. Investors will review those agreements closely, so founders should have a clear understanding of the ownership and licensing structure before diligence begins.

Trade secrets matter too. Fabrication know-how and calibration techniques often stay unpublished on purpose, and a fund will want to understand what you're protecting and how.

How do investors judge commercial viability and the timeline?

Development length shapes everything about the deal. A company expecting commercial revenue in 18 months presents a very different investment case from one with an eight-year development horizon. Both can be investable, but the milestones, capital requirements, and expectations need to reflect the real timeline. Investors look for realistic timelines with measurable milestones, because credibility depends in part on setting expectations the company can reasonably execute against.

Commercial viability comes down to whether the technology can solve a meaningful problem better than available alternatives, and whether a real market is likely to exist when the product is ready.

What investors check What convinces them
First application A specific use case tied to a meaningful customer problem
Technical milestones A staged roadmap with dates, budgets, and clear success criteria
Non-dilutive funding / early commercial validation Research contracts, government programs, or strategic partnerships that support development
Competitive position Why your approach still matters if a rival's hardware improves faster
Team scaling A hiring plan matched to the technical milestones still ahead

The road from research to product should be clear even to someone who isn't an expert in the company's specific area of quantum technology: where the science stands today, the next two or three technical milestones and what each one makes commercially possible, who pays along the way, and what the first real product looks like. Government grants, national quantum programs, and enterprise research partnerships can all play an important role in financing long development cycles. Strategic partnerships may also provide early signals of market interest alongside the capital they provide.

A useful example: a team demonstrates a measurable improvement in error rates, publishes it, signs a research agreement with a pharmaceutical company for molecular simulation work, and maps three milestones over four years toward a system that customers would buy. For investors, a roadmap like this makes a long development cycle easier to evaluate because technical progress, commercial interest, and capital needs are connected through measurable milestones.

If you're building a company in quantum computing and thinking about your next funding round, we'd be glad to hear from you. Reach out to us directly at [email protected].

Pitango Venture Capital Management Israel Ltd published this content on October 15, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 15, 2026 at 10:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]